GDUFA/BsUFA User Fees Explained @accessiblemeds
GDUFA/BsUFA User Fees Explained  @accessiblemeds
Uploaded June 2022 | Updated November 2026, 3 hours ago
What are GDUFA/BsUFA user fees? Watch this video to learn more about how the Generic Drug User Fee Amendments (GDUFA) and Biosimilar User Fee Act (BsUFA) help to get more generic and biosimilar medicines to patients more quickly.

Over ten years, the generic and biosimilar industry has provided the FDA over $4 billion for review and approval of lower-cost treatments for America’s patients. The result is more than $2 trillion in savings to patients and a dramatic increase in patient access to life-saving treatments.

Learn more: accessiblemeds.org/advocacy/gdufa-bsufa-user-fees
GDUFA/BsUFA User Fees ExplainedSavings from Biosimilars since 2015 #GRxBiosimsSavingsReportBriefing: How NAFTA/Trade Policy Proposals Undermine Trump Administration Drug Pricing BlueprintAAM Lifetime Achievement Award - Joe RennerJoin us a GRx+Biosims 2021 — Progress + ProcessAAM Lifetime Achievement Award at Access! 2022GRx+Biosims 2022Christine Simmon: Policy and Biosimilars Sessions at the GRx+Biosims 2020 Virtual ConferencePatient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeekGeneric Drugs Are the Prescription for Savings. Dont Take Them for Granted.The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMedsMessage from CEO Dan Leonard on Access! 2021
Association for Accessible Medicines |

GDUFA/BsUFA User Fees Explained

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER